Ebola virus (EBOV) causes sever hemorrhagic fever in humans, can cause death 19 in a large percentage of those infected, and still lacks FDA approved treatment 20 options. In this study, we investigated how the essential EBOV protein, VP40, 21 forms stable oligomers to mediate budding and assembly from the host cell 22 plasma membrane. An array of in vitro and cellular assays identified and 23 characterized two lysine rich regions that bind to PI(4,5)P 2 and serve distinct 24 2 functions through the lipid binding and assembly of the viral matrix layer. We 25 found that when VP40 binds PI(4,5)P 2 , VP40 oligomers become extremely stable 26 and long lived. Together, this work characterizes the molecular basis of PI(4,5)P 2 27 binding by VP40, which stabilizes formation of VP40 oligomers necessary for 28 viral assembly and budding. Quercetin, a natural product that lowers PI(4,5)P 2 in 29 the plasma membrane, inhibited budding of VP40 VLPs and may inform future 30 treatment strategies against EBOV. 31 32 Introduction: 33
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Introduction: 33

Ebola virus (EBOV) is a lipid-enveloped pleomorphic virus that can infect a wide 34
variety of human cells causing significant disease 1, 2 . To date there are no FDA 35 approved drugs or vaccines for EBOV treatment and there is still a great deal of 36 need in understanding how to therapeutically target the five different types of 37 ebolaviruses. The EBOV glycoprotein (GP), which studs the exterior of the virus 38 particle during the infection scheme, has been the major target of vaccine 39 development and antibody based therapies. Indeed, a vaccine using EBOV GP 40 pseudotyped into vesicular stomatitis virus is being implemented in the current 41 EBOV outbreak in the Democratic Republic of Congo 3 . While many of the 42 emerging treatments aimed at the GP show great promise, the GP has been 43 shown to mutate significantly during the course of the recent outbreak 4-6 and a 44 watch list of potential GP antibody escape mutants has been generated 7 . Thus, 45 other targets in the viral life cycle are being explored such as host-viral 46 interactions 8 and the matrix protein VP40 [8] [9] [10] . 47 VP40 is the matrix protein of EBOV and required for viral assembly, budding 48 and viral spread [11] [12] [13] [14] [15] [16] . As the most abundantly expressed EBOV protein, VP40 49 achieves several distinct and essential tasks to ensure viral success. VP40 is a 50 transformer protein with several structures known, including a monomer 17 , dimer, 51 hexamer and octamer 18 . Initially, VP40 enters the nucleus of the host cell post 52 viral entry 19 , likely binds RNA as an octamer and regulates viral genome 53 replication 18, 20 . Subsequently, VP40 dimers interact with host lipids such as 54 phosphatidylserine (PS) 21, 22 to localize to the plasma membrane (PM) 18, 22 and 55 form stable hexamers 18, 21, [23] [24] [25] . Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) 56 at the host PM inner leaflet is required for large VP40 oligomers to form 26 from 57 PS induced VP40 hexamers 18, [21] [22] [23] [24] [25] . 58
Despite an important role for PS and PI(4,5)P 2 in the EBOV life cycle and 59
budding from the host cell PM, the molecular basis and structural consequences 60 of VP40-lipid interactions are mostly unknown. Notably, the VP40 dimer is 61 necessary for PM localization whereas the monomer is not sufficient for 62 trafficking to the PM 18, 22 . Dimer interactions with PM lipids are purported to 63 induce structural changes to form VP40 hexamers 18, 21, [23] [24] [25] 27 and larger 64 oligomers forming the viral matrix layer 23, 26 . Notably, the VP40 octamer has been 65 shown to play an important role in the regulation of viral transcription 18 and has 66 not been detected at the PM nor in virions or VLPs. Additionally, the VP40 67 octamer was found to have a significant reduction in PS affinity compared to the 68 VP40 dimer 22 . 69
Previously, we found that VP40 requires PI(4,5)P 2 at the plasma 70 membrane for the formation of large self-oligomers, VLP formation, and VLP 71 budding 26 . A recent molecular dynamics model found VP40 hexamers cluster 72 PI(4,5)P 2 but not PS at the PM through C-terminal lysine residues 28 . In this study, 73
we investigate the VP40 lipid binding properties at the PM and the structural 74 consequences of interactions with PS and PI(4,5)P 2 . Results demonstrate that 75 PI(4,5)P 2 provides significant structural stability to VP40 hexamers that form 76 following interactions with PS. PI(4,5)P 2 provides extensive stability to the viral 77 matrix layer through two distinct PI(4,5)P 2 binding sites, loss of which leads to 78 rapid dissociation of VP40 oligomers and inhibition of viral budding. Further, a 79 natural product Quercetin, which reduces plasma membrane PI(4,5)P 2 80 significantly inhibited VLP formation from the PM. Taken together, these new 81 findings account for the molecular basis of PI(4,5)P 2 recognition by VP40, 82 PI(4,5)P 2 induced structural stability and assembly of VP40, and open up a 83 potentially new avenue for EBOV treatment. 84
Results: 85
Hypothesized PI(4,5)P 2 binding site is conserved among ebolaviruses: 86 VP40 from Zaire, Sudan, Tai Forest, Bundibugyo, and Reston ebolaviruses were 87 aligned using uniprot to reveal sequence conservation in residues hypothesized 88 to bind to PI(4,5)P 2 . lysine residues (blue) and the 270's lysine residues (green) formed distinct, 97 adjacent domains ( Figure 1B) . 98 VP40 binds to PI(4,5)P 2 containing membranes with high selectivity among 99
phosphoinositides: 100
Figure 1: Ebola VP40 sequence and structure revels two PI(4,5)P 2 binding sites. A. Consensus sequence of Ebola VP40 strains several lysine residues in the 220 and 270 regions of the protein are positioned at the surface of the C-terminal domain. Sequence alignment was performed with uniprot alignment tools. B. Zaire VP40 hexamer structure (4ldd with modeled Cterminal domains) with Region 1 (220 lysine residues) colored in blue and Region 2 (270 lysine residues) colored in green.
Surface plasmon resonance (SPR) was used to determine the affinity of 124 VP40 for PI(4,5)P 2 as previously described 32 . Using this technique, we found that 125 the VP40 dimer binds to PI(4,5)P 2 containing LUVs with an apparent affinity of 126 170 nM (Figure 2) . This binding affinity is also slightly stronger than the 127 interaction between VP40 and POPS, also determined with SPR 21 . 128 VP40 binds to PI(4,5)P 2 through lysine residues in CTD Region 1 and 129
Region 2: 130
To determine which VP40 residues are responsible for PI(4,5)P 2 131 interactions, lipid binding of VP40 lysine mutants was tested in vitro using a the 132 LUV assay detailed above. Binding to liposomes containing 5% PI(4,5)P 2 was 133 Representative SDS PAGE bands from the large unilamellar (LUV) pelleting assay with DPPC:Cholesterol without (control) or with 5% of one of the seven phosphatidylinositol phosphate species. B. Quantified VP40 fraction bound to liposomes (protein found in pellet fraction). The average value is plotted and shown ± the SEM. C. Representative surface plasmon resonance curve of VP40 binding to liposomes containing 5% PI(4,5)P 2 gave an average binding affinity of 170 nM with a standard error of the mean of 26 nM. * P<0.05, ** P<0.001, ***P<0.00001 measured for the dimer of VP40-WT and select lysine mutants. VP40-K104A and 134 K236A did not have a significant difference in binding to PI(4,5)P 2 LUVs 135 compared to the WT protein (Figure 3) . In contrast, K221A, K224A, K225A, 136 K270A, K274A, K275A, and K279A had significant decreases in binding to LUVs 137 containing PI(4,5)P 2 compared to WT (Figure 3) . 138 PI(4,5)P 2 binding residues are critical for the VP40 budding phenotype in 139 PI(4,5)P 2 in the structure and assembly of the viral matrix layer. 173
We assessed the oligomer formation of VP40 mutants and found that 174 K221A, K224A, and K225A had a dramatic and significant reduction in oligomers 175 larger than a hexamer (Figure 6 ). For these mutants, there was also a significant 176 increase in the hexamer population compared to WT VP40. K270A, K274A, and 177 K275A also had a significant decrease in oligomers larger than a hexamer but 178 may not be a major contributor to PI(4,5)P 2 dependent assembly but a role in 196 interdomain interactions cannot be discounted at this time. K279A also showed 197 a significant decrease in budding which is consistent with the reduction in binding 198 homogeneous sample, elevated levels of PI(4,5)P 2 or PS were used ( Figure S4) . 212
Samples were incubated for 10,100, 1000, 10,000 and 100,000 seconds (s). 213
Changes in deuterium incorporation during these time points are shown in 214 figures 5, 7, and 9 show the influence of PC, PS, and PI(4,5)P 2 , respectively. 217 Figure S10 shows the HDX data mapped onto the dimer structure and Figure  218 S11 shows the influence of each lipid on the VP40 dimer structure at 10,000 s. 219
The deuterium incorporations for each time point and lipid were also mapped to 220 the VP40 hexamer structure, the relevant structure for VP40 matrix assembly 18 . 221 Figure 8A shows the percent deuterium incorporation mapped to the 222 hexamer structure while Figure 8B shows the influence of PC, PS, and PI(4,5)P 2 223 on the hexamer structure. In the presence of PC, VP40 deuterium exchange is 224 slightly increased compared to without lipid as shown by the light red regions in 225 the NTD. The VP40 structural changes observed through decreased deuterium 226 incorporation after binding PI(4,5)P 2 were very stable with less than 20% change 227 in deuterium incorporation between the 10 s and 100,000 s time points. The 228 majority of decreases in deuterium incorporation were lost in the PS samples 229 after the 10,000s time point (Figure 8C-D) . Again, this data strongly supports a 230 model where PS is important for initial membrane association and VP40 231 conformational change whereas PI(4,5)P 2 plays a more predominant role in 232 stabilizing the VP40 oligomers that form. shown to interact with PS, and the HDX supports these observations as the 240 deuterium exchange was reduced for PS containing vesicles slightly greater than 241 Figure 8 . HDX-MS reveals changes in VP40 solvent accessibility when co incubated with various liposomes. A. Deuteration level of VP40 (shown as the hexamer) at 10 s, 10,000 s and 100,000 s time points after a 30 minute incubation with Control liposomes, PS containing liposomes, or PI(4,5)P 2 containing liposomes. B. The influence of Control liposomes, PS containing liposomes, or PI(4,5)P 2 containing liposomes on VP40 deuteration is mapped onto the VP40 hexamer structure for the 10 s, 10,000 s and 100,000 s time points. C. The influence of PI(4,5)P 2 containing liposomes on VP40 PI(4,5)P 2 binding residues is enlarged. Deuterium incorporation in these regions is plotted in the peptide map to the right of the region of interest. The y-axis is the number of deuterium incorporated into the peptide fragment with respect to time on the x-axis. D. The influence of PI(4,5)P 2 containing liposomes on VP40 PI(4,5)P 2 residues hypothesized to be important for the stabilization of large oligomers (residues 57-73). Deuterium incorporation in these regions is plotted in the peptide map to the right of the region of interest. formation and formation of large VP40 oligomers (Figure 6-7) . 248
The most dramatic changes observed were seen in the NTD residues 57-249 73, a novel site likely important for VP40 oligomer stability. Residues 57-73 are 250 seen packed against the N-N terminal alpha helical interface ( Figure 8D) . The 251 N-N terminal dimer interface is retained in the hexamer structure; this structure is 252 extremely stable and no deuterium is incorporated even after 100,000 s under all 253 conditions (Figure S5-S10) . PI(4,5)P 2 and PS both significantly reduced 254 deuterium incorportation in this N-terminal domain oligomerization interface 255
(residues 57-73), with PI(4,5)P 2 providing greater stability over the lifetime of the 256 experiments again underscoring the importance of PI(4,5)P 2 in VP40 hexamers 257 and large oligomers. 258
Molecular Dynamics Section 259
To gain more molecular insight into PI(4,5)P 2 coordination by VP40, we 260 performed molecular dynamics simulations of VP40 dimer and hexamers with 261 bilayers containing PI(4,5)P 2 . PI(4,5)P 2 was shown to cluster at the ends of the 262 VP40 hexamers where interactions between Lys residues in CTD regions 1 and 263 2 occurred (Figure 9) . The H-bonding was monitored over the lifetime of the (Fig. 9D) (Fig. S14) . 279 VP40 budding is reduced when PI(4,5)P 2 is depleted with small molecule 280
inhibitors: 281
To determine if pharmacological inhibition of PI(4,5)P 2 synthesis was a 282 feasible approach to inhibit VLP formation, we employed cellular treatments with 283
Phenylarsine oxide (PAO) and Quercetin (Q), which have been used to suppress 284 PI(4,5)P 2 synthesis 34 . Cell viability was assessed with various concentrations of 285 each drug using the Cell TiterGlo assay kit (see Methods section). Q is a natural 286 product found in many foods [35] [36] [37] [38] [39] and has been reported as a tyrosine 287 phosphatase inhibitor 40 , lipid kinase inhibitor 34 , as well as an anti-microbial, 288 pancreatic lipase inhibitor, and HIV inhibitor 41 . We are interested in the PI5 289 kinase inhibitory effects of Q, which was shown to inhibit PI(4,5)P 2 synthesis at 290 the PM 34 . Additionally, HIV-GAG requires PI(4,5)P 2 for efficient virus particle 291 release and a 40 μM treatment of cells with Q, resulted in 80% inhibition of viral 292 spread 41 . PAO was also shown to inhibit PI(4,5)P 2 synthesis though inhibition of 293 PI4 kinase IIIα 34 . Previously, we found that a 10 μM, 30 minute PAO treatment 294 significantly reduced VP40 localization from the PM 26 . 295
Here we tested lower concentrations of these pharamacological agents 296 over a longer treatment time. Confocal imaging of PLCδ-PH with each treatment 297 showed a significant but not complete depletion of PI(4,5)P 2 from the PM of cells 298 with 500 nM PAO or 100 μM Q compared to the respective DMSO vehicle 299 controls ( Figure 10A ). The population of cells transfected with VP40 that formed 300
VLPs was also reduced significantly ( Figure 10A) . Next, VLPs and CL samples 301 were collected and the percent budding was determined with western blot 302 analysis for PAO and Q treatments (Figure 10C and 10D) . The VP40 expression 303 was lower in PAO and Q treated cells but the loading control, GAPDH, did not 304 show changes in expression. PAO treated cells had a ~30% decrease in budding 305 compared to the DMSO control, which was not statistically significant over three 306 independent VLP collections. Higher concentrations of PAO are used for more 307 complete PI(4,5)P 2 depletion in cells, however, these concentrations were toxic 308 to cells over longer treatment times ( Figure S12 ). Q treated cells had a 309 statistically significant decrease in budding when compared to the DMSO control. 310 Q treatment in Phase I clinical trials recommended a 1400 mg/m 2 intravenous 311 treatment 42 . Because PLCδ-PH showed that not all PM PI(4,5)P 2 is depleted at 312 this concentration of Q, we hypothesize additional Q effects are resulting in the 313 more dramatic decrease in VP40 VLP budding than with PAO treatment. 314
Additional research will prove useful to more closely investigate the mechanism 315 of Q on VP40 function especially as this molecule is a natural product with low 316
toxicity. 317 318
Discussion: 319
VP40 binds selectively to PI(4,5)P 2 over the other seven 320 phosphatidylinositol lipids (Figure 2A and 2B) . The apparent affinity for 321 PI(4,5)P 2 containing LUVs is approximately 170 nM ( Figure 2C ) and this affinity 322 would likely be increased though avidity with VP40 oligomers and likely PI(4,5)P 2 323 induced clustering in the cellular environment 28 . Binding of VP40 to PI(4,5)P 2 is 324 mediated in part by lysine residues in region 1 (K221, K224, K225) and region 2 325 (K270, K274, K275, K279), which contributed to plasma membrane localization, 326 VP40 oligomerization, and budding (Figures 3-7) . Interestingly, these two 327 binding regions have distinct VP40 phenotypes. For example, region 1 lysine 328 residues are required for the formation for oligomers larger than a hexamer 329 whereas region 2 lysine residues harbor more significantly reduced VLP 330 formation but didn't have as a profound of an effect on the formation of large 331 VP40 oligomers. This data is in agreement with the confocal imaging and 332 assessment of cell populations with VLPs (Figure 4 ) and SEM imaging (Figure  333 
5). 334
The HDX MS data confirmed these VP40 binding sites are distinct as they 335 have different deuterium incorporations when bound to PI(4,5)P 2 liposomes. HDX 336 MS was recently used to study Marburg virus VP40 (mVP40) oligomerization and 337 lipid binding 43 . mVP40 interacts with anionic membranes through electrostatic 338 interactions 44 and HDX MS confirmed that these interactions occur via CTD 339 residues and that mVP40 undergoes oligomer formation when bound to anionic 340 membranes. In contrast to eVP40, the lifetime of the mVP40 interactions with 341 anionic membranes was relatively short 43 . In region 1 of VP40, PS contributed to 342 a slower exchange rate with deuterium than that of PI(4,5)P 2 and this region was 343 more important for formation of VP40 oligomers larger than a hexamer. We hypothesize that binding to negatively charged PI(4,5)P 2 or PS at this site 386 could initiate the unlatching of the potential K104-D193 salt bridge. 387 PAO and Q treatments reduced the overall VP40 expression levels but Q 388 had a significant effect on VLP formation whereas PAO did not. This observation 389 raises the question whether VP40 requires PI(4,5)P 2 for efficient expression and 390 stability. VP40 enters the nucleus during viral infection 19 and there is a pool of 391 nuclear PI(4,5)P 2 that is not completely understood 46 . Alternatively, there is a 392 self-inhibitory effect on VP40 expression if VP40 membrane binding cannot be 393 achieved. The VP40 octamer formation and RNA binding event is critical for viral 394 success, but the VP40 RNA sequence specificity is still unknown. Additionally, 395 the role of VP40 octamer in the nucleus is undetermined but found to be 396 essential for viral success 18 . Additional studies will enhance this mysterious 397
Here we found that 100 μM Q treatment and 500 nM PAO treatment result in a 403 decrease in PI(4,5)P 2 at the plasma membrane in consonance with previous 404 reports 34 . Interestingly, Q had a greater inhibitory effect on budding than PAO. 
Surface plasmon resonance (SPR). SPR measurements were made using a 471
Biacore X (GE Healthcare) with an L1 sensor Chip (GE Healthcare). Liposomes 472 were prepared by hydrating lipid films in 10 mM TRIS, pH 7.4 containing 150 mM 473 NaCl followed by extrusion through a 100 nm filter. All experiments were 474 performed at room temperature in 150 mM NaCl, 10 mM TRIS, pH 7.4 using the or not were counted. VP40-EGFP mutants were compared to WT. Each 494 construct was counted and imaged over at least three independent experiments. 495
For number and brightness experiments, an Olympus FV1000 instrument was 496 used according to the procedure explained in depth previously 47 Scientific). Blots were imaged on a GeneGnome (Syngene, India). ImageJ was 520 used to quantify band density and determine budding efficiency. 521
Hydrogen Deuterium Exchange Mass Spectrometry (HDX MS). HDX MS 522
experiments were performed as described in detail previously with Marburg VP40 523 43 . For Ebola VP40, multilamellar vesicles (MLVs) of the following compositions 524 were used: PC (50% POPC, 50% DOPE), 12.5% PI(4,5)P 2 (47.5% POPC, 40% 525 DOPE, 12.5% PI(4,5)P 2 ), and 60% POPS (30% POPC, 10% DOPE, 60% 526 POPS). 3 ug protein and 2.8 mM MLV were incubated 30 minutes prior to the 527 HDX experiments. HDX data was analyzed as previously described in detail Both dimer-membrane systems were solvated using TIP3 water 573 molecules. The total system consists of around 361000 atoms (PIP 2 setup) and 574 around 121,000 atoms for (POPI set up). We performed all-atom molecular 575 dynamics simulations using NAMD2.10 50 with the CHARMM36 force field for both 576 systems. The particle mesh Ewald (PME) method was used in order to treat long 577 range electrostatic interaction and the SHAKE algorithm was employed to 578 constrain hydrogen-containing covalent bonds. The system was minimized for 579 10,000 steps followed by a six step equilibration process. Pressure was 580 controlled using a Nose-Hoover Langevin-piston method. Langevin temperature 581
coupling with a friction coefficient of 1 ps -1 was used to control the temperature 582 and a 2 fs time step was used for production runs. Missing residues were added using the Modeller software package. The plasma 587 membrane and hexamer system was built 28 using the Charmm-gui webserver 49 . 588 the lower leaflet. Since the total number of atoms was greater than 600,000 591 atoms, a coarse grained (CG) model was constructed to reduce the number of 592 particles so that computational simulations of hundreds of nanoseconds were 593 feasible. For CG simulations, we used the Martini 2.0 force field, where four 594 heavy (non-hydrogen) atoms were mapped onto a single bead, excluding 595 residues with aromatic side chains. The lipids were modelled as in Gc et al. 28 and 596
Van Der Spoel et al. 51 . The system was solvated using standard Martini water 597 beads and was neutralized in 0.15 M NaCl. The total number of particles for the 598 CG system was 52827. 599
